## MLM: Martin Marietta Materials, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 3.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($617.43)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Will Extending Its US$800 Million Credit Facility to 2030 Change Martin Marietta’s (MLM) Narrative?**
- Source: Simply Wall Street | 20251223T030847 | Somewhat-Bullish | Relevance: 100%
- Martin Marietta Materials (MLM) has extended its US$800 million revolving credit facility to December 21, 2030, enhancing liquidity and funding visibility. While this provides near-term financial certainty, the company's long-term success still hinges on US infrastructure spending and disciplined capital allocation. The extension supports management's confident outlook, even with a high debt load, and should be considered alongside the broader market’s diverse fair value estimates.

**2. Martin Marietta Materials (MLM): Evaluating Valuation After a Steady Three-Year Share Price Climb**
- Source: Sahm | 20251222T120812 | Somewhat-Bullish | Relevance: 100%
- Martin Marietta Materials (MLM) has seen its share price climb steadily, up about 5% in the last month and 24% this year, driven by investor focus on infrastructure and construction demand. While a narrative fair value suggests the stock is 4.9% undervalued at $666, its market ratios, with a P/E of 32.3x against a fair ratio of 23.2x, indicate it might be overvalued compared to historical norms and peers. This discrepancy highlights a debate over whether the market has already factored in future growth or if fundamental upside remains.

**3. Will Extending Its US$800 Million Credit Facility to 2030 Change Martin Marietta’s (MLM) Narrative?**
- Source: Simply Wall Street | 20251223T033632 | Somewhat-Bullish | Relevance: 99%
- Martin Marietta Materials recently extended its US$800 million revolving credit facility until 2030, enhancing its liquidity and funding visibility. This move supports the company's growth ambitions, underpinned by raised 2025 revenue and earnings guidance. However, the investment narrative still heavily relies on continued infrastructure spending and disciplined capital allocation, with high capital intensity and leverage remaining key considerations for investors.

**4. Pervious Concrete Pavers Market Is Going to Boom |• BASF SE • CEMEX S.A.B. de C.V.**
- Source: openPR.com | 20251223T011015 | Somewhat-Bullish | Relevance: 74%
- Worldwide Market Reports has released a new research study on the "Pervious Concrete Pavers Market," predicting substantial growth in the coming years. The comprehensive report analyzes market dynamics, drivers, restraints, and opportunities across various segments and regions. Key players like BASF SE, CEMEX S.A.B. de C.V., and Holcim Group are highlighted in this study that covers both historical performance and future growth forecasts.

**5. Squarepoint Ops LLC Buys Shares of 5,137 Eagle Materials Inc $EXP**
- Source: MarketBeat | 20251222T140957 | Neutral | Relevance: 71%
- Squarepoint Ops LLC recently initiated a new position in Eagle Materials Inc (NYSE:EXP), acquiring 5,137 shares valued at approximately $1.04 million, bringing institutional ownership to 96.07%. Analyst sentiment for Eagle Materials is mixed, with a consensus "Hold" rating and an average price target of $236.30, following some recent target reductions. The company recently missed EPS estimates but exceeded revenue expectations, declared a quarterly dividend of $0.25, and saw an insider share purchase.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $690 | $660 | +5% |
| 2025-12-15 | Jefferies | $730 | $725 | +1% |
| 2025-12-01 | Morgan Stanley | $660 | $610 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Jefferies | main | Buy |
| 2025-12-01 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.12M) |
| Sells | 7 ($0.61M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+1.3%)
- JPMORGAN CHASE & CO: 9.7% (+98.6%)
- Blackrock Inc.: 6.9% (-1.8%)
- FMR, LLC: 4.8% (-4.3%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.58 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 17%). Balance sheet: strong liquidity (3.0x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.8B |
| Beta | 1.16 |
| 52W Range | $441.95 - $665.18 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.58 |
| Forward P/E | 28.9 |
| Current P/E | 34.3 |
| YoY Growth | 18.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.6% to 0.2% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.82), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.17% (CS: 76) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | 1.82 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.118x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $642.63
- **Stop Loss:** $617.43 (3.9% risk)
- **Target:** $667.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 35
- **Position Value:** $22,492.05
- **Portfolio %:** 22.49%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-02-11 (Est: $4.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.68 | $6.85 | +2.5% |
| 2025Q2 | $5.26 | $5.43 | +3.2% |
| 2025Q1 | $1.88 | $1.90 | +1.1% |
| 2024Q4 | $4.56 | $4.81 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*